Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client

Executive Summary

• Cannabix Technologies announced its first commercial sales of the Marijuana Breath Test (MBT) to a major construction contractor in the Pacific Northwest via an authorized reseller.
• The MBT detects recent cannabis use (delta‑9 THC) in breath within ~4 hours, addressing safety‑critical needs in construction and other high‑risk industries.
• The company highlights a strategic partnership with Omega Laboratories for laboratory analysis and projects expanding adoption across safety‑sensitive sectors.

Key Details

• First Commercial Delivery: MBT units sold to a large regional construction contractor (industrial, civil, commercial) for workplace safety testing.
• Product Capability: Detects delta‑9 THC in breath at >5 pg/L within approximately four hours of use, aligning with impairment‑relevant timeframes.
• Technology Components:
• Cannabix Breath Collection Unit (BCU)
• Single‑use disposable Breath Cartridges
• Laboratory Developed Test (LDT) method performed by Omega Laboratories using LC‑MS.
• Target Markets: Construction, transportation, logistics, warehousing, manufacturing – industries with strict safety mandates and high injury rates.
• Strategic Partnership: Ongoing collaboration with Omega Laboratories Inc., a global forensic drug‑testing leader with 25+ years of experience.
• CEO Quote: “Our Marijuana Breath Test provides a modern, scientifically grounded way to identify recent cannabis use in a fair and non‑invasive manner… This first commercial delivery … is an important milestone that supports safer operations.” – Rav Mlait, CEO.
• Commercial Outlook: Company expects growing interest from large employers facing regulatory pressure, insurance requirements, and demand for precise impairment testing; plans to scale production and expand reseller network.
• Forward‑Looking Statements: Includes expectations on market adoption, manufacturing scale‑up, recurring revenue, future partnerships, regulatory approvals, and potential financings.

Notable Quotes

“As cannabis use continues to expand across the United States, safety‑sensitive industries are struggling with outdated drug testing methods that do not reflect real‑world workplace needs,” said Rav Mlait, CEO of Cannabix Technologies Inc.

All boilerplate, safe‑harbor language, and disclaimer sections have been omitted for clarity.